#peanut_amr RESEARCH :mag_right: :hospital: :space_invader:	![Python](https://img.shields.io/badge/python-3670A0?style=for-the-badge&logo=python&logoColor=ffdd54)  ![Pandas](https://img.shields.io/badge/pandas-%23150458.svg?style=for-the-badge&logo=pandas&logoColor=white) ![NumPy](https://img.shields.io/badge/numpy-%23013243.svg?style=for-the-badge&logo=numpy&logoColor=white)


In this study, we utilized the reduced eICU database, dividing patients into specific microorganism-antibiotic blocks determined by experts for predicting the possible future resistance:

Block 1: Extended-spectrum β-lactamase-producing Enterobacteriaceae (assumed based on resistance to cefotaxime, ceftriaxone, ceftazidime, and cefepime)

- E. coli
- Klebsiella pneumoniae
- Enterobacter cloacae
- Enterobacter sp
- Klebsiella oxytoca
- Proteus mirabilis

Block 2: Carbapenemase-producing Enterobacteriaceae (assumed based on resistance to meropenem and imipenem)

- E. coli
- Klebsiella pneumoniae
- Enterobacter cloacae
- Enterobacter sp
- Klebsiella oxytoca
- Proteus mirabilis
  
Block 3: Carbapenem-resistant (meropenem and imipenem)

- Pseudomonas aeruginosa
- Acinetobacter baumannii
  
Block 4: Trimethoprim/sulfamethoxazole-resistant

- Stenotrophomonas maltophilia

Block 5: Vancomycin-resistant

- Enterococcus faecium

Block 6: Oxacillin-resistant

- Staphylococcus aureus

The study outcomes are as follows:
By Block:

|Block|sensitivitylevel|Count|
|:----|:----|:----|
|Bloque 1: BLEE|No resistant|315|
|Bloque 2: Carbapenemasas|No resistant|89|
|Bloque 6: oxacilina|Resistant|58|
|Bloque 6: oxacilina|No resistant|56|
|Bloque 1: BLEE|Resistant|52|
|Bloque 3: Carbapenémicos|No resistant|32|
|Bloque 3: Carbapenémicos|Resistant|7|
|Bloque 4: trimetropin/sulfacetozaxol|No resistant|4|
|Bloque 5: vancomicina|No resistant|4|
|Bloque 5: vancomicina|Resistant|4|
|Bloque 2: Carbapenemasas|Resistant|2|


By Block and Senstivity Level: 

|Block|sensitivitylevel|Count|
|:----|:----|:----|
|Bloque 1: BLEE|No resistant|315|
|Bloque 2: Carbapenemasas|No resistant|89|
|Bloque 6: oxacilina|Resistant|58|
|Bloque 6: oxacilina|No resistant|56|
|Bloque 1: BLEE|Resistant|52|
|Bloque 3: Carbapenémicos|No resistant|32|
|Bloque 3: Carbapenémicos|Resistant|7|
|Bloque 4: trimetropin/sulfacetozaxol|No resistant|4|
|Bloque 5: vancomicina|No resistant|4|
|Bloque 5: vancomicina|Resistant|4|
|Bloque 2: Carbapenemasas|Resistant|2|



